Viewing nowCombinationRobaduet Tablet 10/5 mg
Rosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 202004614 · Approved 2020.06.23 · Insurance code 649605850
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps reduce total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing good cholesterol, HDL cholesterol levels. It is primarily used as an adjunct to dietary therapy and should be applied together with improvements in eating habits. When using lipid-modifying drugs in individuals at high risk of atherosclerotic vascular disease, multiple risk factors should be considered, and this medication is chosen when non-pharmacological treatment is not sufficient. Additionally, it is important to confirm secondary causes such as diabetes and hypothyroidism prior to treatment and to address them first if necessary. By following a diet that includes caloric and fat intake restrictions, this medication can be used effectively to manage blood lipid levels, thus helping to improve hypercholesterolemia and reduce the risk of cardiovascular disease.
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.
This medication may rarely cause side effects affecting the muscles, such as muscle pain or weakness, and in severe cases, it could lead to serious muscle damage known as rhabdomyolysis, which might affect kidney function. Therefore, patients with severe muscle symptoms or at high risk of kidney problems should temporarily discontinue or cease the use of this medication. This medication should not be used by individuals allergic to the active ingredient or its components, those with severe liver dysfunction, individuals with muscle diseases, those with very low kidney function, pregnant women or women of childbearing potential, and nursing mothers. Particularly, patients with severe kidney impairment, hypothyroidism, a family history of muscle disease, those who have experienced muscle toxicity from similar medications in the past, individuals with excessive alcohol consumption, Asians, and those taking fibrate medications should be prohibited from taking this medication in high doses. This medication contains lactose and should not be taken by patients with lactose intolerance or certain genetic lactose metabolism disorders. Patients with a history of alcohol abuse or liver disease, those with moderate to severe liver dysfunction, those at high risk of developing myopathy, elderly individuals, those taking fibrate medications, and patients with severe muscle weakness should exercise caution when using this medication and consult a physician immediately if muscle pain or adverse drug effects occur during treatment. While taking this medication, liver function tests and muscle enzyme levels should be monitored regularly, and any symptoms should be reported to healthcare professionals immediately. Pregnant or nursing women should not use this medication due to potential risks to the fetus or baby, and women of childbearing age should employ proper contraception. Safety in children and adolescents has not been adequately established; therefore, it is not recommended. This medication may interact with other drugs, so patients taking anticoagulants, fibrate medications, certain antibiotics, antifungals, or immunosuppressants should inform their physician. In case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, along with monitoring liver and muscle function.
Acute renal failure caused by myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory tract infection, elevated blood sugar, increased serum CPK, chest discomfort, dizziness, drowsiness, neurodegenerative disorders, positional dizziness, migraine, diabetes mellitus, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, dermatophyte infection of nails, soft tissue inflammation, fatty liver, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, kidney dysfunction, benign esophageal neoplasm, angioedema, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, myasthenia gravis, ocular myasthenia, constipation, nausea, abdominal pain, pancreatitis, pruritus, asthenia, arthralgia, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, increased creatine phosphokinase, myopathy, rhabdomyolysis, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, cholelithiasis, cholecystitis, tremors, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, conjunctival injection, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Pink, rectangular film-coated tablet
30 tablets/PTP [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.